Literature DB >> 15765151

Arterial and renal consequences of partial genetic deficiency in tissue kallikrein activity in humans.

Michel Azizi1, Pierre Boutouyrie, Alvine Bissery, Mohsen Agharazii, Francis Verbeke, Nora Stern, Alessandra Bura-Rivière, Stéphane Laurent, François Alhenc-Gelas, Xavier Jeunemaitre.   

Abstract

Tissue kallikrein (TK), the major kinin-forming enzyme, is synthesized in several organs, including the kidney and arteries. A loss-of-function polymorphism of the human TK gene (R53H) induces a substantial decrease in enzyme activity. As inactivation of the TK gene in the mouse induces endothelial dysfunction, we investigated the vascular, hormonal, and renal phenotypes of carriers of the 53H allele. In a crossover study, 30 R53R-homozygous and 10 R53H-heterozygous young normotensive white males were randomly assigned to receive both a low sodium-high potassium diet to stimulate TK synthesis and a high sodium-low potassium diet to suppress TK synthesis, each for 1 week. Urinary kallikrein activity was 50-60% lower in R53H subjects than in R53R subjects. Acute flow-dependent vasodilatation and endothelium-independent vasodilatation of the brachial artery were both unaffected in R53H subjects. In contrast, R53H subjects consistently exhibited an increase in wall shear stress and a paradoxical reduction in artery diameter and lumen compared with R53R subjects. Renal and hormonal adaptation to diets was unaffected in R53H subjects. The partial genetic deficiency in TK activity is associated with an inward remodeling of the brachial artery, which is not adapted to a chronic increase in wall shear stress, indicating a new form of arterial dysfunction affecting 5-7% of white people.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15765151      PMCID: PMC1052005          DOI: 10.1172/JCI23669

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  45 in total

1.  Urinary kallikrein and plasma renin activity as determinants of renal blood flow. The influence of race and dietary sodium intake.

Authors:  S B Levy; J J Lilley; R P Frigon; R A Stone
Journal:  J Clin Invest       Date:  1977-07       Impact factor: 14.808

2.  Low-salt diet downregulates plasma but not tissue kallikrein-kinin system.

Authors:  U Hilgenfeldt; T Puschner; U Riester; J Finsterle; J Hilgenfeldt; E Ritz
Journal:  Am J Physiol       Date:  1998-07

3.  Familial aggregation of urinary kallikrein concentration in childhood: relation to blood pressure, race and urinary electrolytes.

Authors:  S H Zinner; H S Margolius; B Rosner; H R Keiser; E H Kass
Journal:  Am J Epidemiol       Date:  1976-08       Impact factor: 4.897

4.  Urinary kallikrein excretion in hypertensive man. Relationships to sodium intake and sodium-retaining steroids.

Authors:  H S Margolius; D Horwitz; J J Pisano; H R Keiser
Journal:  Circ Res       Date:  1974-12       Impact factor: 17.367

5.  Interactions among erythrocytes under shear.

Authors:  D E Brooks; J W Goodwin; G V Seaman
Journal:  J Appl Physiol       Date:  1970-02       Impact factor: 3.531

6.  Human urinary kallikrein converts inactive to active renin and is a possible physiological activator of renin.

Authors:  J E Sealey; S A Atlas; J H Laragh; N B Oza; J W Ryan
Journal:  Nature       Date:  1978-09-14       Impact factor: 49.962

7.  Kallikrein along the rabbit microdissected nephron: a micromethod for its measurement. Effect of adrenalectomy and DOCA treatment.

Authors:  J Marchetti; M Imbert-Teboul; F Alhenc-Gelas; J Allegrini; J Menard; F Morel
Journal:  Pflugers Arch       Date:  1984-05       Impact factor: 3.657

8.  Role of tissue kallikrein in response to flow in mouse resistance arteries.

Authors:  Sonia Bergaya; Khalid Matrougui; Pierre Meneton; Daniel Henrion; Chantal M Boulanger
Journal:  J Hypertens       Date:  2004-04       Impact factor: 4.844

9.  A circadian variation in the excretion of urinary kinin, kallikrein and prostaglandin E in normal volunteers.

Authors:  K Abe; M Sato; Y Kasai; T Haruyama; K Sato; S Miyazaki; Y Imai; M Hiwatari; T Itoh; Y Sakurai; T Goto; J Tajima; M Seino; K Yoshinaga
Journal:  Jpn Circ J       Date:  1981-09

10.  Effects of dietary potassium and race on urinary excretion of kallikrein and aldosterone in man.

Authors:  D Horwitz; H S Margolius; H R Keiser
Journal:  J Clin Endocrinol Metab       Date:  1978-08       Impact factor: 5.958

View more
  13 in total

1.  Vascular remodeling and the kallikrein-kinin system.

Authors:  Oscar A Carretero
Journal:  J Clin Invest       Date:  2005-03       Impact factor: 14.808

Review 2.  A new look at electrolyte transport in the distal tubule.

Authors:  Dominique Eladari; Régine Chambrey; Janos Peti-Peterdi
Journal:  Annu Rev Physiol       Date:  2011-09-02       Impact factor: 19.318

Review 3.  Unleashing the therapeutic potential of human kallikrein-related serine proteases.

Authors:  Ioannis Prassas; Azza Eissa; Gennadiy Poda; Eleftherios P Diamandis
Journal:  Nat Rev Drug Discov       Date:  2015-02-20       Impact factor: 84.694

4.  Tissue kallikrein is essential for invasive capacity of circulating proangiogenic cells.

Authors:  Gaia Spinetti; Orazio Fortunato; Daniela Cordella; Paola Portararo; Nicolle Kränkel; Rajesh Katare; Graciela B Sala-Newby; Christine Richer; Marie-Pascale Vincent; Francois Alhenc-Gelas; Giancarlo Tonolo; Sara Cherchi; Costanza Emanueli; Paolo Madeddu
Journal:  Circ Res       Date:  2010-12-16       Impact factor: 17.367

5.  Tissue kallikrein stimulates Ca(2+) reabsorption via PKC-dependent plasma membrane accumulation of TRPV5.

Authors:  Dimitra Gkika; Catalin N Topala; Qing Chang; Nicolas Picard; Stéphanie Thébault; Pascal Houillier; Joost G J Hoenderop; René J M Bindels
Journal:  EMBO J       Date:  2006-09-28       Impact factor: 11.598

Review 6.  The kallikrein-kinin system as a regulator of cardiovascular and renal function.

Authors:  Nour-Eddine Rhaleb; Xiao-Ping Yang; Oscar A Carretero
Journal:  Compr Physiol       Date:  2011-04       Impact factor: 9.090

7.  Serine Protease Activation Essential for Endothelial-Mesenchymal Transition in Vascular Calcification.

Authors:  Jiayi Yao; Pierre J Guihard; Ana M Blazquez-Medela; Yina Guo; Jeremiah H Moon; Medet Jumabay; Kristina I Boström; Yucheng Yao
Journal:  Circ Res       Date:  2015-08-11       Impact factor: 17.367

8.  Critical role of tissue kallikrein in vessel formation and maturation: implications for therapeutic revascularization.

Authors:  Oliver A Stone; Christine Richer; Costanza Emanueli; Vincent van Weel; Paul H A Quax; Rajesh Katare; Nicolle Kraenkel; Paola Campagnolo; Luciola S Barcelos; Mauro Siragusa; Graciela B Sala-Newby; Danila Baldessari; Marina Mione; Marie P Vincent; Andrew V Benest; Ayman Al Haj Zen; Julien Gonzalez; David O Bates; Francois Alhenc-Gelas; Paolo Madeddu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-01-22       Impact factor: 8.311

9.  Endothelial-Mesenchymal Transition in Vascular Calcification of Ins2Akita/+ Mice.

Authors:  Pierre J Guihard; Jiayi Yao; Ana M Blazquez-Medela; Luisa Iruela-Arispe; Kristina I Boström; Yucheng Yao
Journal:  PLoS One       Date:  2016-12-09       Impact factor: 3.240

Review 10.  Human tissue kallikrein in the treatment of acute ischemic stroke.

Authors:  Michelle Alexander-Curtis; Rick Pauls; Julie Chao; John J Volpi; Philip M Bath; Todd A Verdoorn
Journal:  Ther Adv Neurol Disord       Date:  2019-01-20       Impact factor: 6.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.